Roles of Serotonergic and Adrenergic Receptors in the Antinociception of Selective Cyclooxygenase-2 Inhibitor in the Rat Spinal Cord
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background:The analgesic mechanisms of cyclooxygenase (COX)-2 inhibitors have been explained mainly on the basis of the inhibition of prostaglandin biosynthesis. However, several lines of evidence suggest that their analgesic effects are mediated through serotonergic or adrenergic transmissions. We investigated the roles of these neurotransmitters in the antinociception of a selective COX-2 inhibitor at the spinal level. Methods:DUP-697, a selective COX-2 inhibitor, was delivered through an intrathecal catheter to male Sprague-Dawley rats to examine its effect on the flinching responses evoked by formalin injection into the hindpaw. Subsequently, the effects of intrathecal pretreatment with dihydroergocristine, prazosin, and yohimbine, which are serotonergic, a1 adrenergic and a2 adrenergic receptor antagonists, respectively, on the analgesia induced by DUP-697 were assessed. Results:Intrathecal DUP-697 reduced the flinching response evoked by formalin injection during phase 1 and 2. But, intrathecal dihydroergocristine, prazosin, and yohimbine had little effect on the antinociception of intrathecal DUP-697 during both phases of the formalin test. Conclusions:Intrathecal DUP-697, a selective COX-2 inhibitor, effectively relieved inflammatory pain in rats. Either the serotonergic or adrenergic transmissions might not be involved in the analgesic activity of COX-2 inhibitors at the spinal level. (Korean J Pain 2011; 24: 179-184)
Abstract
Background:The analgesic mechanisms of cyclooxygenase (COX)-2 inhibitors have been explained mainly on the basis of the inhibition of prostaglandin biosynthesis. However, several lines of evidence suggest that their analgesic effects are mediated through serotonergic or adrenergic transmissions. We investigated the roles of these neurotransmitters in the antinociception of a selective COX-2 inhibitor at the spinal level. Methods:DUP-697, a selective COX-2 inhibitor, was delivered through an intrathecal catheter to male Sprague-Dawley rats to examine its effect on the flinching responses evoked by formalin injection into the hindpaw. Subsequently, the effects of intrathecal pretreatment with dihydroergocristine, prazosin, and yohimbine, which are serotonergic, a1 adrenergic and a2 adrenergic receptor antagonists, respectively, on the analgesia induced by DUP-697 were assessed. Results:Intrathecal DUP-697 reduced the flinching response evoked by formalin injection during phase 1 and 2. But, intrathecal dihydroergocristine, prazosin, and yohimbine had little effect on the antinociception of intrathecal DUP-697 during both phases of the formalin test. Conclusions:Intrathecal DUP-697, a selective COX-2 inhibitor, effectively relieved inflammatory pain in rats. Either the serotonergic or adrenergic transmissions might not be involved in the analgesic activity of COX-2 inhibitors at the spinal level. (Korean J Pain 2011; 24: 179-184)
참고문헌 (27)
- Beiche F, "Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation", FEBS Lett, 390, pp.165~169 (1996)
- Cheol Hun Choi, "Roles of Opioid Receptor Subtype in the Spinal Antinociception of Selective Cyclooxygenase 2 Inhibitor", The Korean Journal of Pain, 23(4), pp.236~241 (2010), 대한통증학회
- Hamza M, "Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition", Curr Mol Pharmacol, 2, pp.1~14 (2009)
- Marlier L, "Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord", Brain Res, 550, pp.15~23 (1991)
- Hösli E, "Evidence for the existence of alpha- and beta-adrenoceptors on neurones and glial cells of cultured rat central nervous system--an autoradiographic study", Neuroscience, 7, pp.2873~2881 (1982)
- Fürst S, "Transmitters involved in antinociception in the spinal cord", Brain Res Bull, 48, pp.129~141 (1999)
- Sandrini M, "Effect of rofecoxib on nociception and the serotonin system in the rat brain", Inflamm Res, 51, pp.154~159 (2002)
- Taiwo YO, "Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses", J Neurosci, 8, pp.1346~1349 (1988)
- Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~1036 (1976)
- 최정일, "백서를 이용한 포르말린 시험하에서 척수강내 Gabapentin의 항침해작용에 대한 Serotonergic 수용체의 영향", The Korean Journal of Pain, 15(1), pp.19~25 (2002), 대한통증학회
- Coppi G, "Dihydroergocristine. A review of pharmacology and toxicology", Arzneimittelforschung, 42, pp.1381~1390 (1992)
- Grognet JM, "The pharmacokinetics of dihydroergocristine after intravenous and oral administration in rats", Arzneimittelforschung, 42, pp.1394~1396 (1992)
- Doxey JC, "Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors", Br J Pharmacol, 78, pp.489~505 (1983)
- Hamilton CA, "Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit", Br J Pharmacol, 86, pp.79~87 (1985)
- Hubbard JW, "The pharmacokinetic properties of yohimbine in the conscious rat", Naunyn Schmiedebergs Arch Pharmacol, 337, pp.583~587 (1988)
- MyungHaYoon, "Spinal Gabapentin and Antinociception: Mechanisms of Action", Journal of Korean Medical Science, 18(2), pp.255~261 (2003), 대한의학회
- Puig S, "Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity", Pain, 64, pp.345~355 (1996)
- Nishiyama T, "Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats", Acta Anaesthesiol Scand, 50, pp.228~233 (2006)
- Pini LA, "Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid", Pharmacology, 54, pp.84~91 (1997)
- Vitale G, "Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain", Gen Pharmacol, 31, pp.753~758 (1998)
- Courade JP, "Effects of acetaminophen on monoaminergic systems in the rat central nervous system", Naunyn Schmiedebergs Arch Pharmacol, 364, pp.534~537 (2001)
- Bonnefont J, "Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism", Anesthesiology, 99, pp.976~981 (2003)
- Fairbanks CA, "Spinal delivery of analgesics in experimental models of pain and analgesia", Adv Drug Deliv Rev, 55, pp.1007~1041 (2003)
- Xu JJ, "Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance", Anesth Analg, 103, pp.714~720 (2006)
- Pinardi G, "Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems", Inflammation, 25, pp.233~239 (2001)
- Miranda HF, "An isobolographic analysis of the adrenergic modulation of diclofenac antinociception", Anesth Analg, 93, pp.430~435 (2001)
- Miranda HF, "Isobolographic analysis of the antinociceptive interactions of clonidine with nonsteroidal anti-inflammatory drugs", Pharmacol Res, 50, pp.273~278 (2004)